International Journal of Molecular Sciences, Volume 25, Issue 13
2024 July-1 - 690 articles
Cover Story: Hepatocellular carcinoma (HCC) is the most frequent among primary liver tumors and one of the main causes of cancer-related death. It typically develops in a chronically inflamed environment, ranging from compensatory parenchymal regeneration to fibrosis and cirrhosis. Inflammation determined by chronic viral infection represents an important risk factor for HCC etiology through both viral direct damage and immune-related mechanisms. The deregulation of the physiological liver immunological network determined by viral infection can lead to carcinogenesis. The recent introduction of immunotherapy as the gold-standard first-line treatment for HCC highlights the role of the immune system and inflammation as a double-edged weapon in both HCC carcinogenesis and treatment. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.